Herbert Tilg

7 ta ish

Innsbruck Medical University

1. Management of <i>Helicobacter pylori</i> infection: the Maastricht VI/Florence consensus report

   Peter Malfertheiner, Françis Mégraud, Theodore Rokkas +12

   Maqola20225 iqtibos

   ABIABI:AkademIndex/2026.other.444221

2. A guiding map for inflammation

   Mihai G. Netea, Frances R. Balkwill, Michel Chonchol +29

   Maqola20174 iqtibos

   ABIABI:AkademIndex/2026.other.591507

3. Global burden of metabolic diseases, 1990–2021

   Huai Zhang, Xiaodong Zhou, Michael D. Shapiro +53

   MaqolaOAOchiq kirishDiabetes, Cardiovascular Risks, and LipoproteinsMetabolism20242 iqtibos

   ABIABI:AkademIndex/2024.article.000002

4. An international multidisciplinary consensus statement on MAFLD and the risk of CVD

   Xiaodong Zhou, Giovanni Targher, Christopher D. Byrne +45

   MaqolaOAOchiq kirish20232 iqtibos

   ABIABI:AkademIndex/2026.other.015805

5. Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits Hypothesis

   Herbert Tilg, Alexander R. Moschen

   Sharh maqola20102 iqtibos

   ABIABI:AkademIndex/2026.other.536075

6. Visfatin, an Adipocytokine with Proinflammatory and Immunomodulating Properties

   Alexander R. Moschen, Arthur Kaser, Barbara Enrich +4

   Maqola20072 iqtibos

   ABIABI:AkademIndex/2026.other.583255

7. COVID-19 and the gastrointestinal tract: more than meets the eye

   Siew C. Ng, Herbert Tilg

   Boshqa20202 iqtibos

   ABIABI:AkademIndex/2026.other.720636